Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11160%2F07%3A00006715" target="_blank" >RIV/00216208:11160/07:00006715 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man
Original language description
Three members of the aldo-keto reductase (AKR) superfamily were found and identified to mediate oracin carbonyl reduction in man
Czech name
Aldo-keto reduktasy (AKR) z podrodiny AKR1C katalyzují u člověka karbonylovou redukci nového protinádorového léčiva oracinu
Czech description
Byly nalezeny a identifikovány tři enzymy z nadrodiny aldo-keto reduktas (AKR), které se účastní karbonylové redukce oracinu člověka
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
CE - Biochemistry
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2007
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Toxicology
ISSN
0300-483X
e-ISSN
—
Volume of the periodical
238
Issue of the periodical within the volume
2-3
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
8
Pages from-to
111-118
UT code for WoS article
—
EID of the result in the Scopus database
—